What the EU MDR delay due to the Coronavirus pandemic means for you May 14, 2020 The new EU Medical Device Regulation was pushed back a year. What do you do? We interviewed Sparta Systems project managers for their perspectives.Q: As of April 2020, EU MDR has been delayed by a year. What does that mean?A: In light of the COVID-19 pandemic, the European Commission has approved a 1-year delay in the implementation and enforcement of the new European Union Medical Device Regulation. Q: What new requirements were captured in the EU MDR? Have there been any changes other than the delay?A: The purpose was to update and tighten regulation of medical devices in the EU. There have been no changes to the MDR as a whole except the Date of Application delay. Q: Why would the novel coronavirus pandemic have an effect on this regulation rollout?A: The COVID-19 outbreak and the impact that the resulting response is having several effects that impact this change in timing of the regulation. The industry is focused generally on dealing with frontline response to COVID-19, which is of immediate need to alleviate medical product shortages, the lack of diagnostics, and the lack of trusted and qualified therapies.The regulatory arm (FDA, EMA and NB) is focused on maintaining a state of control in the industry while acknowledging the immediate need for new and changed medical products and enabling the fast-track evaluation of new treatments.Given the restrictions on travel, stay-at-home orders, and the like, the usual paradigm of meeting, planning, and collaborating internally to meet the new requirements, albeit delayed, are also disrupted. Q: Is the delay for Date of Application (DoA) the only change that impacted MDR project at my site, or is the impact more substantial?A: The delay was implemented, but COVID-19 impacted MDR projects in other ways as well: Resources that had been assigned to MDR preparation have been pulled into other more critical project directly reacting to COVID-19 or have been directly impacted by COVID-19.Momentum Loss. Meetings that had been ongoing have been deprioritized, meaning that decisions and actions come slower or not at all.Economic ramifications have limited use of, and access to, external resources such as consultancy, software, and other product and service suppliers. Q: What is important to know about managing current processes that are disrupted?A: Imperatively, knowledge needs to be preserved. If a project is disrupted but expected to be revived, documenting current state while hibernating the project is critical. Critical data around open tasks and project risks need to be captured and recorded. Include timeline projections for when the situation has passed to aid in resource allocation and optimal manufacturing output. During the pause or disruption, actively monitor the situation externally to determine the resumption timeline. Factors to consider include resource availability, onboarding, ramp up, and changes in teams. Q: When the process is revived, how should we work smart through it?When the workflow is opened back up again, that effort of knowledge capture will smooth the transition. Start with a re-discovery to re-assess scope, resources, and risks and determine or confirm deliverables. Do not assume conditions are the same as before a hibernation period. Confirm new current state against any other changes that may have occurred during the hibernation.Evaluate the suitability of the original plan (not only milestone dates) with respect scope or resource changes.Timelines will be slower in the second project than in the first, due to changes in resources and a need to look back at what was done in the first passExpect the possibility of a decrease in velocity.Re-kickoff may be needed, and a workshop format with key stakeholders may be most productive.Abide by the project management process. Prepare for the new European Medical Device Regulation Share via: Twitter LinkedIn Facebook Email
EVENT Honeywell Life Sciences Innovation Days Honeywell invites you to join us for one of our Life Sciences Innovation Days, a series offered throughout the globe in 2024. We will present a variety of process innovations to support the digital transformation of life sciences manufacturing. Themes will include orchestrating systems and data, preventing and containing cyber incidents, quality control and management, modular automation, and the Honeywell life sciences roadmap. Discussion will address streamlining manufacturing, creating batch records, and fulfilling regulatory reporting requirements. Learn more
EVENT TUG Europe Join industry peers at one of these FREE events for TrackWise and TrackWise Digital customers, with two dates and locations to choose from. Enjoy a networking at our pre-event receptions, as we celebrate 30 years of TrackWise! Take advantage of a FREE TrackWise Digital pre-event training workshop. Learn more
WEBINAR AI-Driven Innovation: Redefining Quality Management in Life Sciences Take a deep dive into the confluence of AI and life sciences, exploring how artificial intelligence is poised to revolutionize the realm of quality management in the sector. Learn more
EBOOK 5 Things to Know About EUDAMED EUDAMED (European database for medical devices) is a centralized database that aims to enhance the transparency and traceability of medical devices in the EU. Learn more
WEBINAR EUDAMED 2024 and Beyond: Preparing for the Future of Medical Device Oversight Watch our on-demand webinar and gain valuable insights into the transformative impact of EUDAMED on the Medical Device industry. Learn more
EVENT Building a Winning Life Science Eco-system – Leveraging the Quality Link between Platform, Processes and Patients Watch this unique webinar to discover how Life Science organizations can a combine a best-in-class platform with freedom of solution choice to improve product quality, productivity, and supply chain continuity. Learn more
CASE STUDY Empowering Innovation: Revelle Aesthetics Transforms Document Management and Training with TrackWise Digital Revelle Aesthetics selected TrackWise Digital to manage its key quality management processes—document management and training management. Learn more
BLOG The Impact of Digital QMS Solutions on the Life Sciences Industry The evolution of cloud-based quality management systems is transforming expectations and changing realities in the life sciences industry. Find out how in our latest newsletter edition. Learn more
BLOG Integrated Risk Management: Go Beyond Compliance To ensure patient safety, proactively detect signals and trends and continuously improve device quality and safety, integrating quality risk management with the quality management system (QMS) is essential. In our latest article, we consider the benefits of this integration and address the growing complexity of risk management. Learn more
BLOG Cultivate a Culture of Quality: 3 Steps to Getting Started Cultivating a quality culture is critical for any organization's long-term success, regardless of industry or size. Learn more
BLOG CAPA Management: Technology to the Rescue If you have been struggling with corrective and preventive action (CAPA) management, it’s possible there is a tech solution that will lift the burden. Learn more
BLOG The Power of Integration: A Holistic Approach to Quality and Document Management One of the key components for Life Sciences companies is to have their documents and data in order.... Learn more
BLOG It’s Time For The Life Sciences Industry To Embrace Quality 4.0 Sparta’s President and CEO, Oxana Karpenko Pickeral, explores how the Life Sciences industry can address core challenges and connect the “data dots” by embracing Quality 4.0. Learn more
WHITE PAPER How Digital Technology Accelerates Your Move to Proactive Quality Leading manufacturers are embracing digitization initiatives to stay competitive in the global economy. Are you one of them? Learn more
BLOG Document Management: A Tale of Two Manufacturers Experiences from two TrackWise Digital customers, Arbor Pharmaceuticals and Mikart, Inc., highlight the challenges that companies can face... Learn more